<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02035865</url>
  </required_header>
  <id_info>
    <org_study_id>REK sør-øst 2013/1260</org_study_id>
    <nct_id>NCT02035865</nct_id>
  </id_info>
  <brief_title>Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)</brief_title>
  <official_title>Nevropsykiatri og Hjertetransplantasjon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim at characterizing neuropsychiatric consequences of heart
      transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on
      mortality and cardiac allograft vasculopathy (CAV).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Psychiatric morbidity</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>Psychiatric diagnoses by clinician and self-rapport</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>Neuropsychological assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>14 and 3 years respectively</time_frame>
    <description>Time since enrollment in former study; i.e. approximately 14 years (study 1) and approximately 3 years (study 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac allograft vasculopathy</measure>
    <time_frame>14 and 3 years respectively</time_frame>
    <description>Time since enrollment in former study; i.e. approximately 14 years (study 1) and approximately 3 years (study 2)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cerebral pathology</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>MRI of the brain</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Psychiatric Diagnosis</condition>
  <condition>Cognition Disorders</condition>
  <arm_group>
    <arm_group_label>Participants from former study 1</arm_group_label>
    <description>Surviving participants from a former study called 'Psykosomale faktorer hos pasienter med hjertesvikt og hos hjertetransplanterte'</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Participants from former study 2</arm_group_label>
    <description>Surviving participants, included at the Norwegian centre, from a study called 'Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE)' (NCT01266148)</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Surviving participants from two former studies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant in one of two former studies and heart transplanted at the time of
             inclusion into this former study

        Exclusion Criteria:

          -  Cognitively not capable to consent to participation and/or

          -  Insufficient fluent in the Norwegian language to complete both psychiatric and
             neuropsychological assessment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ira R. Hebold Haraldsen, MD/dr philos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2013</study_first_submitted>
  <study_first_submitted_qc>January 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2014</study_first_posted>
  <last_update_submitted>April 20, 2015</last_update_submitted>
  <last_update_submitted_qc>April 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Irah Haraldsen</investigator_full_name>
    <investigator_title>MD, dr.philos.</investigator_title>
  </responsible_party>
  <keyword>Psychiatric morbidity</keyword>
  <keyword>Cognitive function</keyword>
  <keyword>Heart transplantation</keyword>
  <keyword>Mortality</keyword>
  <keyword>Cardiac allograft vasculopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

